Tissue factor pathway inhibitor (TFPI) (Extrinsic pathway inhibitor) (EPI) (Lipoprotein-associated coagulation inhibitor) (LACI)
1_MIYTM 6_ KKVHA 11_ LWASV 16_ CLLLN 21_ LAPAP 26_ LNADS 31_ EEDEE 36_ HTIIT 41_ DTELP 46_ PLKLM 51_ HSFCA 56_ FKADD 61_ GPCKA 66_ IMKRF 71_ FFNIF 76_ TRQCE 81_ EFIYG 86_ GCEGN 91_ QNRFE 96_ SLEEC 101_ KKMCT 106_ RDNAN 111_ RIIKT 116_ TLQQE 121_ KPDFC 126_ FLEED 131_ PGICR 136_ GYITR 141_ YFYNN 146_ QTKQC 151_ ERFKY 156_ GGCLG 161_ NMNNF 166_ ETLEE 171_ CKNIC 176_ EDGPN 181_ GFQVD 186_ NYGTQ 191_ LNAVN 196_ NSLTP 201_ QSTKV 206_ PSLFE 211_ FHGPS 216_ WCLTP 221_ ADRGL 226_ CRANE 231_ NRFYY 236_ NSVIG 241_ KCRPF 246_ KYSGC 251_ GGNEN 256_ NFTSK 261_ QECLR 266_ ACKKG 271_ FIQRI 276_ SKGGL 281_ IKTKR 286_ KRKKQ 291_ RVKIA 296_YEEIF
1: Inhibits factor X (X(a)) directly and, in a Xa-dependent way, inhibits VIIa/tissue factor activity, presumably by forming a quaternary Xa/LACI/VIIa/TF complex. It possesses an antithrombotic action and also the ability to associate with lipoproteins in plasma